Canet, L M, Sánchez-Maldonado, J M, Cáliz, R, Rodríguez-Ramos, A, Lupiañez, C B, Canhão, H, Martínez-Bueno, M, Escudero, A, Segura-Catena, J, Sorensen, S B, Hetland, M L, Soto-Pino, M J, Ferrer, M A, García, A, Glintborg, B, Filipescu, I, Pérez-Pampin, E, González-Utrilla, A, Nevot, M Á L, Conesa-Zamora, P, den Broeder, A, De Vita, S, Jacobsen, S E H, Collantes-Estevez, E, Quartuccio, L, Canzian, F, Fonseca, J E, Coenen, M J H, Andersen, V & Sainz, J 2019, ' Correction : Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x) ', Pharmacogenomics Journal, vol. 19, pp. 582 . https://doi.org/10.1038/s41397-019-0084-2